November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreOctober 06, 2025
Based on market forecasts, the life science consulting sector will expand from USD 34.82 billion in 2024 to USD 84.83 billion by 2034, experiencing a CAGR of 9.38%. Globally rising regulatory complexities and demand for cost reduction are fueling the global market growth. North America led the market due to the widespread R&D investment in phar...
October 06, 2025
Based on market forecasts, the medroxyprogesterone acetate (MPA) sector will expand from USD 1.14 billion in 2024 to USD 2.75 billion by 2034, experiencing a CAGR of 9.13%. The rising prevalence of gynecological disorders is estimated to drive the growth of the market. North America led the global market owing to high healthcare expenditure and ins...
October 06, 2025
Projections indicate that, Latin America Behavioral Health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.98 billion by 2034, reflecting a CAGR of 6.74% over the next decade. The market is growing due to rising mental health awareness and digital therapy adoption. In Latin America, growth is driven by expanding healthcare acces...
October 06, 2025
Based on market forecasts, the APAC behavioral health sector will expand from USD 19.07 billion in 2024 to USD 56.58 billion by 2034, experiencing a CAGR of 11.49%. The rising prevalence of mental health disorders and technological advancements drive the market....
October 03, 2025
Market insights predict, the transcriptomics technologies industry is expected to grow from USD 7.01 billion in 2024 to USD 12.79 billion by 2034, driven by a CAGR of 6.24%. The transcriptomics technologies market is growing rapidly because of the growing focus on the development of omics-based therapeutics. North America is leading the market beca...
October 03, 2025
Market insights predict the global biotechnology CMO and CDMO industry will increase from USD 67.25 billion in 2024 to USD 199.67 billion by 2034, achieving a CAGR of 11.54%. The biotechnology CMO and CDMO market is growing because these services help to save pharmaceutical and biotechnology organizations money for manufacturing novel drugs. North ...
October 03, 2025
Market insights predict, the U.S. dental services industry is expected to grow from USD 166.5 billion in 2024 to USD 254.7 billion by 2034, driven by a CAGR of 4.4%. The U.S. dental services market is witnessing growth due to rising government support to provide affordable dental services....
October 03, 2025
Projections indicate that, the U.S. clinical trial imaging market will increase from USD 684 million in 2024 to USD 1675.4 million by 2034, experiencing a CAGR of 9.37% over the next 10 years. Rising pharma & biotech R&D spend/more clinical trials are estimated to drive the growth of the market. Sponsors are running more and larger trials (...
October 03, 2025
According to forecasts, the global meloxicam market will grow from USD 7.62 billion in 2024 to USD 12.23 billion by 2034, with an expected CAGR of 4.84%. The market is growing due to the increasing prevalence of inflammatory and pain-related conditions, along with rising demand for safe, effective NSAID therapies. In North America, the market domin...
October 03, 2025
Projections indicate that, dialectical behavior therapy industry is projected to rise from USD 1.31 billion in 2025 to USD 3.29 billion by 2035, reflecting a CAGR of 9.67% over the next decade. The dialectical behavior therapy market is growing due to the rise in remote patient monitoring approaches. North America’s dominance can be attribute...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com